Table 1.
Vaccines type | Advantages | Disadvantages |
---|---|---|
Peptide | Stable, Safe, Low-complexity antigens, Low toxicity, Easy to transport |
Low immunogenicity in the absence of adjuvants, Unrelated immune response due to degradation, Short half-life |
DNA | Easy fabrication, Low cost, Polyepitope |
Theoretical integration risk, Potential risk of abnormal transcription, Discomfort electroporation |
RNA | Less side effects, Low synthesis expenses, Short synthesis cycle, Simultaneous encoding of multiple antigen sequences, Inadequate restriction of MHC haplotypes |
Unstable, Innate immunogenicity, Easy degradation by RNases, Inefficient delivery, Harsh storage condition |
DC | Low toxicity, Lack of invasive procedures, Potential long-term effects, Conventional antigen presentation pathways |
Time-consuming, High cost, Less feasible to produce at large scale |